The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Fasimec Duo 50 mg/ml + 1 mg/ml oral suspension for sheep

50, 1 milligram(s)/millilitre Oral suspension

Elanco GmbHVPA22020/024/001

Main Information

Trade NameFasimec Duo 50 mg/ml + 1 mg/ml oral suspension for sheep
Active SubstancesTriclabendazole
Strength50, 1 milligram(s)/millilitre
Dosage FormOral suspension
Licence HolderElanco GmbH
Licence NumberVPA22020/024/001

Group Information

ATC CodeQP54AA51 ivermectin, combinations
Therapeutic ClassEndoparasiticide


Licence Issued17/06/2016
Legal StatusLM: Licensed Merchant as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
« Back